Form 4 · Filed Apr 9, 2026, 12:00 PM UTC
IMVT/Immunovant, Inc.
Torti Frank — President and Vant Chair
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | A | other | 174,189 | $0 | — | 1,009,228 |
| Apr 7, 2026 | A | other | 88,325 | $0 | — | 88,325 |
Source: SEC EDGAR raw filing ↗ · Accession 0001764013-26-000052